Search
Amylyx Pharmaceuticals Inc
AMLXAdd to Watchlist
20.310USD
-0.440-2.12%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.26BMarket Cap
LossP/E TTM
Amylyx Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Amylyx Pharmaceuticals Inc is 8.13, ranking 125 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -13.68, which is -3166.04% below the recent high of 419.35 and -44.83% above the recent low of -19.81.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.